These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 8703557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical features and growth fractions of pituitary adenomas.
    Yonezawa K, Tamaki N, Kokunai T.
    Surg Neurol; 1997 Nov; 48(5):494-500. PubMed ID: 9352815
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL, Landolt AM, Jeffreys RV, Diver M, Radcliffe J, White MC.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E, Kovacs K.
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [Abstract] [Full Text] [Related]

  • 9. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 10. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W, Lüdecke B, Lüdecke DK.
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W, Ikeda H, Yoshimoto T.
    Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824
    [Abstract] [Full Text] [Related]

  • 13. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH, Figueroa CD, Smith CM, Bhoola KD.
    Agents Actions Suppl; 1992 Jul 15; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T, Bai X, Liu K, Hu W, Xue D, Jiang X.
    J Tongji Med Univ; 1998 Jul 15; 18(3):161-3. PubMed ID: 10806816
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP.
    Hum Pathol; 2013 Nov 15; 44(11):2400-9. PubMed ID: 24007691
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J, Sáez L, Lemp M, Liberman C, Michelsen H, Araya AV.
    Rev Med Chil; 2008 Jul 15; 136(7):831-6. PubMed ID: 18949157
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.